We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

02 Jun 2026 - 04 Jun 2026
17 Jun 2026 - 19 Jun 2026
05 Oct 2026 - 06 Oct 2026

Anticoagulation Reduces Stroke Risk of Cardioversion

By HospiMedica staff writers
Posted on 24 Oct 2002
In a large study, researchers found that if anticoagulation medication is given to patients with atrial fibrillation prior to cardioversion, the rate of stroke or other embolic happenings was less than 1%.

The study involved 717 patients with atrial fibrillation who had direct current (DC) cardioversion to electronically restore the heart's normal rhythm. More...
Prior to the procedure, all patients were administered anticoagulation medication. The results showed that the medication can greatly minimize the risk of stroke. In the United States alone, the researchers say atrial fibrillation is responsible for more than 70,000 strokes each year. The incidence of atrial fibrillation increases with age. The study was conducted by researchers at the Mayo Clinic (Rochester, MN, USA).

"If the decision favors cardioversion, the researchers have provided further proof of the efficacy of three to four weeks of warfarin anticoagulation before cardioversion,” write doctors from Beth Israel Deaconess Medical Center in Boston (MA, USA) in an accompanying editorial.




Related Links:
Mayo Clinic

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
12-Channel ECG
CM1200B
Medical Examination & Procedure Light
Vega 80
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Elyra TFL System uses thulium fiber laser technology for efficient stone dusting and reduced stone migration, with an air-cooled design for quieter, more compact operation (photo courtesy of BD

BD Launches Elyra Laser Platform for Kidney Stone and Soft Tissue Procedures

BD (Becton, Dickinson and Company) has introduced the Elyra Thulium Fiber Laser (TFL) System, an advanced laser platform developed to complete its kidney stone care portfolio for urology teams.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.